PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.497
https://www.valueinhealthjournal.com/article/S1098-3015(11)02059-6/fulltext
Title :
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02059-6&doi=10.1016/j.jval.2011.08.497
First page :
A322
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
464